Trust Company of Vermont’s bluebird bio BLUE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-11
| Closed | -$54 | – | 1095 |
|
|
2025
Q1 | $54 | Hold |
11
| – | – | ﹤0.01% | 1023 |
|
|
2024
Q4 | $92 | Sell |
11
-2
| -15% | -$17 | ﹤0.01% | 1038 |
|
|
2024
Q3 | $131 | Hold |
13
| – | – | ﹤0.01% | 1032 |
|
|
2024
Q2 | $249 | Hold |
13
| – | – | ﹤0.01% | 871 |
|
|
2024
Q1 | $324 | Hold |
13
| – | – | ﹤0.01% | 824 |
|
|
2023
Q4 | $349 | Hold |
13
| – | – | ﹤0.01% | 740 |
|
|
2023
Q3 | $769 | Hold |
13
| – | – | ﹤0.01% | 778 |
|
|
2023
Q2 | $832 | Hold |
13
| – | – | ﹤0.01% | 789 |
|
|
2023
Q1 | $805 | Hold |
13
| – | – | ﹤0.01% | 833 |
|
|
2022
Q4 | $1.75K | Hold |
13
| – | – | ﹤0.01% | 815 |
|
|
2022
Q3 | $6K | Hold |
13
| – | – | ﹤0.01% | 802 |
|
|
2022
Q2 | $6K | Buy |
+13
| New | +$1.01K | ﹤0.01% | 758 |
|
|
2022
Q1 | – | Sell |
-13
| Closed | -$6K | – | 362 |
|
|
2021
Q4 | $6K | Buy |
+13
| New | +$3.07K | ﹤0.01% | 709 |
|
|
2021
Q3 | – | Sell |
-20
| Closed | -$8K | – | 352 |
|
|
2021
Q2 | $8K | Hold |
20
| – | – | ﹤0.01% | 659 |
|
|
2021
Q1 | $8K | Hold |
20
| – | – | ﹤0.01% | 646 |
|
|
2020
Q4 | $11K | Hold |
20
| – | – | ﹤0.01% | 612 |
|
|
2020
Q3 | $14K | Hold |
20
| – | – | ﹤0.01% | 566 |
|
|
2020
Q2 | $15K | Hold |
20
| – | – | ﹤0.01% | 567 |
|
|
2020
Q1 | $12K | Hold |
20
| – | – | ﹤0.01% | 628 |
|
|
2019
Q4 | $22K | Hold |
20
| – | – | ﹤0.01% | 593 |
|
|
2019
Q3 | $23K | Hold |
20
| – | – | ﹤0.01% | 595 |
|
|
2019
Q2 | $32K | Buy |
20
+6
| +43% | +$10.4K | ﹤0.01% | 544 |
|
|
2019
Q1 | $28K | Buy |
14
+1
| +8% | +$1.76K | ﹤0.01% | 554 |
|
|
2018
Q4 | $17K | Hold |
13
| – | – | ﹤0.01% | 644 |
|
|
2018
Q3 | $25K | Buy |
13
+4
| +44% | +$8.26K | ﹤0.01% | 631 |
|
|
2018
Q2 | $17K | Buy |
+9
| New | +$20.5K | ﹤0.01% | 718 |
|
|
2017
Q1 | – | Sell |
-15
| Closed | -$12K | – | 864 |
|
|
2016
Q4 | $12K | Buy |
+15
| New | +$11.9K | ﹤0.01% | 676 |
|
|
2016
Q3 | – | Sell |
-19
| Closed | -$11K | – | 830 |
|
|
2016
Q2 | $11K | Hold |
19
| – | – | ﹤0.01% | 593 |
|
|
2016
Q1 | $10K | Buy |
19
+4
| +27% | +$2.46K | ﹤0.01% | 596 |
|
|
2015
Q4 | $12K | Buy |
+15
| New | +$15K | ﹤0.01% | 597 |
|
Other funds holding BLUE
Trust Company of Vermont's BLUE Position: Q2 2025 in Review
Trust Company of Vermont sold out of bluebird bio (BLUE) in Q2 2025, closing a stake of 11 shares — an estimated $54 sold.
Trust Company of Vermont first reported a position in BLUE in Q4 2015 and held it in 30 quarters. The position peaked at $32K in Q2 2019. 3 funds tracked by Wall St. Rank hold BLUE as of Q2 2025.
- Trust Company of Vermont reported no remaining bluebird bio position as of Q2 2025 after selling out during the quarter.
- Trust Company of Vermont sold 11 bluebird bio shares in Q2 2025, an estimated $54.
- Trust Company of Vermont first reported a position in bluebird bio in Q4 2015 and held it in 30 quarters.
- Trust Company of Vermont's bluebird bio position peaked at $32K in Q2 2019.
- 3 funds tracked by Wall St. Rank held bluebird bio as of Q2 2025.
Based on Trust Company of Vermont's 13F filing for Q2 2025, filed 18 Jul 2025.